Dorota Urban
Psychiatric/Mental Health · Cheshire, CTNPI 1689047698
Payments from drug & device makers
Across 132 payments — averaging $24.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Alkermes, Inc.$332
- Sunovion Pharmaceuticals Inc.$256
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$175
- Johnson & Johnson$159
- Neurocrine Biosciences, Inc.$151
- plus $920 from 15 others
What the payments were for
- Food & beverage$3,13299%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 56 | $1,184 |
| Alkermes, Inc. | 8 | $332 |
| Sunovion Pharmaceuticals Inc. | 14 | $256 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 9 | $175 |
| Johnson & Johnson | 9 | $159 |
| Neurocrine Biosciences, Inc. | 2 | $151 |
| Axsome Therapeutics, Inc. | 1 | $122 |
| E.r. Squibb & Sons, L.L.C. | 1 | $119 |
| Teva Pharmaceuticals USA, Inc. | 8 | $112 |
| ANI Pharmaceuticals, Inc. | 1 | $111 |
| Amgen | 5 | $105 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $64 |
| Genentech USA, Inc. | 3 | $63 |
| Otsuka America Pharmaceutical, Inc. | 3 | $47 |
| Lundbeck LLC | 2 | $40 |
| Acadia Pharmaceuticals Inc | 2 | $37 |
| Orexo US, Inc. | 1 | $26 |
| Jazz Pharmaceuticals Inc. | 1 | $24 |
| Avanir Pharmaceuticals, Inc. | 1 | $24 |
| Alfasigma USA, Inc. | 1 | $13 |
| Almatica Pharma LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,179 in reported general payments places this provider in the 85th percentile of 679 psychiatric/mental health providers in Connecticut.
See all psychiatric/mental health providers in Connecticut →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bupropion XlBupropion Hcl | 24 | $659 |
| Escitalopram Oxalate | 32 | $394 |
| Eszopiclone | 16 | $359 |
| Lamotrigine | 18 | $325 |
| Clonazepam | 24 | $299 |
| Trazodone Hcl | 13 | $179 |
| Alprazolam | 29 | $102 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Cheshire
- Beatrice PekuCheshire$9K
- Cristina MeehanNew Britain$224K
- Samantha MrazBridgeport$87K
- Philip FrickManchester$31K
- Gia SantoroWest Haven$25K
- Donna DraperDanbury$19K
- Zahida SairitupaDanbury$19K
- Hui HuNorwich$19K
- Patrick GagnonMilford$15K
- Max Greger-MoserNew Haven$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.